Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens

Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens

Detalles Bibliográficos
Autores principales:	Reeve, J, Hesp, R, Audran, M, Renier, J, Slovik, D, Neert, R, Edouard, C, Meunier, P
Formato:	Journal article
Publicado:	1986

Ejemplares similares

The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
por: Hesp, R, et al.
Publicado: (1981)

A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
por: Reeve, J, et al.
Publicado: (1986)

hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
por: Reeve, J, et al.
Publicado: (1991)

Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
por: Reeve, J, et al.
Publicado: (1981)

Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
por: Bradbeer, J, et al.
Publicado: (1992)

Intestinal absorption of calcium in greyhounds: the response to intermittent and continuous administration of human synthetic parathyroid hormone fragment 1-34 (hPTH 1-34).
por: Podbesek, R, et al.
Publicado: (1984)

Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
por: Ebeling, P, et al.
Publicado: (2003)

PTH: a future role in the management of osteoporosis?
por: Reeve, J
Publicado: (1996)

Bone density trends in the distal radius correlate with an index of axial osteoblast depression in osteoporosis
por: Reeve, J, et al.
Publicado: (1986)

Bone formation and osteoid mineralization in osteoporosis
por: Reeve, J, et al.
Publicado: (1984)

Iliac trabecular bone formation predicts radial trabecular bone density changes in type 1 osteoporosis.
por: Hesp, R, et al.
Publicado: (1991)

Temporal variations in iliac trabecular bone formation in vertebral osteoporosis.
por: Arlot, M, et al.
Publicado: (1993)

Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis
por: Sagar Salave, et al.
Publicado: (2023-02-01)

Peripheral and axial measurements of trabecular bone density in patients suspected of idiopathic vertebral osteoporosis.
por: Bydder, G, et al.
Publicado: (1983)

Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
por: Reeve, J, et al.
Publicado: (1987)

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
por: Richard G. Pearson, et al.
Publicado: (2019-06-01)

Human parathyroid peptide treatment of vertebral osteoporosis.
por: Reeve, J, et al.
Publicado: (1993)

The assessment of bone formation and bone resorption in osteoporosis: a comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kinetics.
por: Reeve, J, et al.
Publicado: (1987)

Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
por: Tellez, M, et al.
Publicado: (1995)

A new tracer method for the calculation of rates of bone formation and breakdown in osteoporosis and other generalised skeletal disorders
por: Reeve, J, et al.
Publicado: (1977)

Osteoporosis: cause and management
por: Reeve, J, et al.
Publicado: (1987)

The Effects of Local Treatment of PTH(1-34) and Whitlockite and Hydroxyapatite Graft to the Calvarial Defect in a Rat Osteoporosis Model
por: Jiwoon Jeong, et al.
Publicado: (2024-04-01)

Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry.
por: Arlot, M, et al.
Publicado: (1984)

Characterizing neutrophil response to estrogen during mammary involution
por: Ong, Zoe
Publicado: (2017)

Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34).
por: Yongxin Ren, et al.
Publicado: (2011-01-01)

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
por: Lundkvist, J, et al.
Publicado: (2006)

Trends in trabecular and cortical bone in the radius compared with whole body calcium balance in osteoporosis.
por: Hesp, R, et al.
Publicado: (1984)

Regional bone density measurements compared to total body calcium in osteoporosis
por: Hesp, R, et al.
Publicado: (1982)

Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism
por: Carmina Teresa Fuss, et al.
Publicado: (2020-06-01)

PTH [1–34] induced differentiation and mineralization of mandibular condylar cartilage
por: Mara Heather O’ Brien, et al.
Publicado: (2017-06-01)

Fisiopatología de la osteoporosis y mecanismo de acción de la PTH
por: González Macias J, et al.
Publicado: (2010-05-01)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
por: Lim, Chew Leng, et al.
Publicado: (2020)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
por: Lim, Chew Leng, et al.
Publicado: (2020)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
por: Lim, Chew Leng, et al.
Publicado: (2020)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
por: Chew Leng Lim, et al.
Publicado: (2020-07-01)

Effect of Aerobic Training on Estrogen, PTH, Calcium, Alkaline Phosphatase and Albumin, in Postmenopausal Women
por: Laleh Baghery, et al.
Publicado: (2010-03-01)

Combination Therapy of PTH and Antiresorptive Drugs on Osteoporosis: A Review of Treatment Alternatives
por: Chenggui Zhang, et al.
Publicado: (2021-01-01)

La PTH 1-84 en el tratamiento de la osteoporosis
por: Sosa Henríquez M, et al.
Publicado: (2010-07-01)

Manejo exitoso de hipoparatiroidismo con PTH (1-34) o teriparatide
por: Severiche Bueno Severiche Bueno, et al.
Publicado: (2021-11-01)

Potential effects of teriparatide (PTH (1–34)) on osteoarthritis: a systematic review
por: Guoqing Li, et al.
Publicado: (2023-01-01)